Evercore Wealth Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$430K Buy
+2,235
New +$241K 0.01% 302
2023
Q1
– Sell
-1,287
Closed -$231K – 415
2022
Q4
$231K Buy
+1,287
New +$210K ﹤0.01% 363
2022
Q2
– Sell
-1,235
Closed -$213K – 419
2022
Q1
$213K Sell
1,235
-4
-0.3% -$673 ﹤0.01% 410
2021
Q4
$315K Hold
1,239
– – 0.01% 348
2021
Q3
$477K Buy
1,239
+4
+0.3% +$1.48K 0.01% 293
2021
Q2
$290K Buy
+1,235
New +$221K 0.01% 367

Other funds holding MRNA

Evercore Wealth Management's MRNA Position: Q3 2026 in Review

Evercore Wealth Management opened a new position in Moderna (MRNA) in Q3 2026: 2,235 shares worth $430K. The stake represents 0.01% of the portfolio and ranks #302 among its holdings. This is a return to the name: Evercore Wealth Management previously reported a position in MRNA as recently as Q4 2022.

Evercore Wealth Management first reported a position in MRNA in Q2 2021 and has held it in 6 quarters since. The position peaked at $477K in Q3 2021. 1,044 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Evercore Wealth Management held 2,235 shares of Moderna worth $430K as of Q3 2026.
  • Moderna was a new Evercore Wealth Management position in Q3 2026.
  • Moderna made up 0.01% of Evercore Wealth Management's portfolio in Q3 2026, its #302 holding.
  • Evercore Wealth Management first reported a position in Moderna in Q2 2021 and has held it in 6 quarters since.
  • Evercore Wealth Management's Moderna position peaked at $477K in Q3 2021.
  • 1,044 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Evercore Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.